Cargando…

Point-Of-Care Urine LAM Tests for Tuberculosis Diagnosis: A Status Update

Most diagnostic tests for tuberculosis (TB) rely on sputum samples, which are difficult to obtain and have low sensitivity in immunocompromised patients, patients with disseminated TB, and children, delaying treatment initiation. The World Health Organization (WHO) calls for the development of a rap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bulterys, Michelle A., Wagner, Bradley, Redard-Jacot, Maël, Suresh, Anita, Pollock, Nira R., Moreau, Emmanuel, Denkinger, Claudia M., Drain, Paul K., Broger, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020089/ https://www.ncbi.nlm.nih.gov/pubmed/31906163 http://dx.doi.org/10.3390/jcm9010111

Ejemplares similares

Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
por: Kerkhoff, Andrew D., et al.
Publicado: (2020)

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients
por: Broger, Tobias, et al.
Publicado: (2019)

“SILVAMP TB LAM” Rapid Urine Tuberculosis Test Predicts Mortality in Patients Hospitalized With Human Immunodeficiency Virus in South Africa
por: Sossen, Bianca, et al.
Publicado: (2020)

Barriers to Access to New Gonorrhea Point-of-Care Diagnostic Tests in Low- and Middle-Income Countries and Potential Solutions: A Qualitative Interview-Based Study
por: Ferreyra, Cecilia, et al.
Publicado: (2020)

The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis
por: Ricks, Saskia, et al.
Publicado: (2020)

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers
por: Singhroy, Diane N., et al.
Publicado: (2020)

Rapid Urine LAM Testing Improves Diagnosis of Expectorated Smear-Negative Pulmonary Tuberculosis in an HIV-endemic Region
por: Drain, Paul K., et al.
Publicado: (2016)

User perspectives and preferences on a novel TB LAM diagnostic (Fujifilm SILVAMP TB LAM)–a qualitative study in Malawi and Zambia
por: Herrmann, Yannis, et al.
Publicado: (2022)

Innovative COVID-19 point-of-care diagnostics suitable for tuberculosis diagnosis: a scoping review protocol
por: Yerlikaya, Seda, et al.
Publicado: (2023)

Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review
por: Lawn, Stephen D
Publicado: (2012)

Diagnostic accuracy of 3 urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients
por: Broger, Tobias, et al.
Publicado: (2020)

Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis
por: Reither, Klaus, et al.
Publicado: (2009)

Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data
por: Broger, Tobias, et al.
Publicado: (2020)

Diagnostic Accuracy of Urine Lipoarabinomannan Testing in Early Morning Urine versus Spot Urine for Diagnosis of Tuberculosis among People with HIV
por: Bjerrum, Stephanie, et al.
Publicado: (2022)

Discovery of a unique Mycobacterium tuberculosis protein through proteomic analysis of urine from patients with active tuberculosis
por: Pollock, Nira, et al.
Publicado: (2018)

Can Point-of-Care Urine LAM Strip Testing for Tuberculosis Add Value to Clinical Decision Making in Hospitalised HIV-Infected Persons?
por: Peter, Jonathan G., et al.
Publicado: (2013)

Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients
por: Huerga, Helena, et al.
Publicado: (2020)

Toward the Development of a Circulating Free DNA-Based In Vitro Diagnostic Test for Infectious Diseases: a Review of Evidence for Tuberculosis
por: Fernández-Carballo, B. Leticia, et al.
Publicado: (2019)

The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America
por: Picado, Albert, et al.
Publicado: (2018)

Uptake of the lateral flow urine LAM test in Europe and Central Asia
por: Kraef, C., et al.
Publicado: (2022)

Detection of Mycobacterium tuberculosis transrenal DNA in urine samples among adult patients in Peru
por: Mesman, Annelies W, et al.
Publicado: (2023)

Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis
por: Seid, Getachew, et al.
Publicado: (2022)

Economic considerations support C-reactive protein testing alongside malaria rapid diagnostic tests to guide antimicrobial therapy for patients with febrile illness in settings with low malaria endemicity
por: Lubell, Yoel, et al.
Publicado: (2019)

Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections
por: Mapamba, Daniel Adon, et al.
Publicado: (2023)

Diagnostic Accuracy of a Novel and Rapid Lipoarabinomannan Test for Diagnosing Tuberculosis Among People With Human Immunodeficiency Virus
por: Bjerrum, Stephanie, et al.
Publicado: (2019)

Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors
por: Brümmer, Lukas E., et al.
Publicado: (2022)

Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies
por: Lawn, Stephen D, et al.
Publicado: (2013)

Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Comments on the article ‘Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis’
por: Keikha, Masoud
Publicado: (2022)

Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study
por: Broger, Tobias, et al.
Publicado: (2019)

Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: a Systematic Review and Meta-analysis
por: Lee, Rose A., et al.
Publicado: (2021)

The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected Persons
por: Rajasingham, Radha, et al.
Publicado: (2017)

Wifredo Lam
por: Fouchet, Max-Pol
Publicado: (1989)

Wifredo Lam
por: Lam, Wifredo
Publicado: (1978)

Wifredo Lam /
por: Fouchet, Max-Pol

Wifredo Lam
por: Núñez Jiménez, Antonio

Lymphangioleiomyomatosis (LAM)
Publicado: (2017)

Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV
por: Boyles, Tom H., et al.
Publicado: (2018)

Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) for Diagnosis of Active Tuberculosis in HIV-Infected Adults: a Prospective Cohort Study
por: Na Songkhla, Munjit, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3j77n514t84dicsqm2grhhjeh9